Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Danusa Damásio"'
Autor:
Cristiane Ritter, Larissa Constantino, Monique Michels, Renata Casagrande Gonçalves, Cassiana Fraga, Danusa Damásio, Felipe Dal-Pizzol
Publikováno v:
Revista Brasileira de Terapia Intensiva, Vol 32, Iss 1, Pp 108-114 (2020)
RESUMO Objetivo: Avaliar a efetividade da estratificação para identificar e escolher alvos para terapia antioxidante em um modelo de sepse letal em animais e pacientes que desenvolveram hipotensão prolongada. Métodos: Submeteu-se um grupo de rato
Externí odkaz:
https://doaj.org/article/3c192c4cd483402fb62b310e7cce51c3
Autor:
Monique Michels, Cristiane Ritter, Angeles M. Vitali, Danusa Damásio, Cleonice Maria Michelon, Felipe Dal-Pizzol
Publikováno v:
Journal of Geriatric Psychiatry and Neurology. 32:119-136
Delirium is a serious and common disorder that affects up to 80% of acutely ill patients, mainly the aged. In recent years, several studies pointed out possible biomarkers that could be used alone or in combination with other resources in the diagnos
Autor:
Renata C. Gonçalves, Monique Michels, Cristiane Ritter, Felipe Dal-Pizzol, Danusa Damásio, Larissa Constantino, Cassiana Mazon Fraga
Publikováno v:
Revista Brasileira de Terapia Intensiva. 32
Autor:
Cristiane, Ritter, Larissa, Constantino, Monique, Michels, Renata Casagrande, Gonçalves, Cassiana, Fraga, Danusa, Damásio, Felipe, Dal-Pizzol
Publikováno v:
Revista Brasileira de Terapia Intensiva
Objective To examine the effectiveness of stratification to identify and target antioxidant therapy for animal models of lethal sepsis and in patients who develop sustained hypotension. Methods Rats were subjected to sepsis induced by cecal ligation
Autor:
Cassiana Mazon Fraga, Cristiane Damiani Tomasi, Francieli Vuolo, Felipe Dal-Pizzol, Cristiane Ritter, Danusa Damásio
Publikováno v:
Critical Care
The aim was to test the primary hypothesis that in patients suffering from shock, treatment with N-acetylcysteine (NAC) plus deferoxamine (DFX) decreases the incidence of acute kidney injury (AKI). A double-blind, randomized, placebo-controlled trial